Collision-Dated Inflammatory Panels for Attorneys

Why Collision-Dated Inflammatory and Metabolic Panels Prove Aggravation Under the Texas Eggshell Plaintiff Rule

Abstract
Collision-dated inflammatory and metabolic panels give attorneys a practical way to show traumatic aggravation when the defense points to pre-existing disease. Directed by Dr. Maria Guadalupe Cardenas, MD, markers such as high-sensitivity C-reactive protein (hs-CRP), selected cytokines, and metabolic indicators can be timed to the collision. In addition, the same results identify modifiable factors that support Advanced IV protocols and targeted nutrition in future-care costs. These results remain coordinated with the patient’s primary physician.

A defense medical examiner opens the file and notes that the patient’s last annual labs already showed elevated cholesterol and a mildly raised CRP. The expert concludes the post-crash fatigue, stiffness, and pain are simply the continuation of long-standing metabolic disease. For the attorney, that argument is familiar. However, under the Texas Eggshell Plaintiff Rule, the defendant remains responsible for the additional harm caused by the collision even when the patient entered the event with an existing vulnerability. The practical task is to separate the pre-accident baseline from the acute change that followed the impact.

Timed laboratory panels offer one of the clearest ways to make that separation. When blood is drawn in a defined window after the collision, and the results are compared with earlier records, an acute-phase response can be distinguished from chronic background inflammation. Moreover, the same data can also document the medical necessity for supportive care that reduces reliance on long-term pharmaceuticals.

How the Eggshell Rule Operates in Practice

Texas pattern jury charges distinguish aggravation of a symptomatic pre-existing condition from injury to a previously asymptomatic vulnerability. In either setting, the at-fault party is liable for the incremental harm produced by the trauma. Defense experts frequently treat any laboratory abnormality discovered after the collision as proof that the patient’s condition was already present and unchanged. Without a dated comparison, the argument is difficult to rebut.

Collision-dated panels close that gap. An hs-CRP value that rises sharply within days to a couple of weeks after impact, then trends downward as structural care proceeds, is consistent with an acute inflammatory response rather than stable chronic disease. In addition, studies of traumatic injury, including work from the TRACK-TBI cohort, have shown that hs-CRP elevations in the early post-injury period carry prognostic information distinct from baseline metabolic risk (Xu et al., 2021). Cytokine patterns (IL-6, TNF-α, and related mediators) further characterize the response. Also, metabolic markers—fasting insulin, HOMA-IR, lipid particle measures, or micronutrient indices—may shift when trauma-induced inflammation impairs insulin signaling or increases oxidative demand.

These findings do not, by themselves, prove legal proximate cause. They do, however, provide objective, time-stamped evidence that the collision produced a measurable physiologic change in a patient who already had a metabolic vulnerability. That distinction is precisely what the Eggshell Rule requires.

The Clinical Utility of Dr. Cardenas-Directed Panels

Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine and Medical Director at Injury Medical Clinic PA, oversees the selection and interpretation of these panels. Typical elements include:

• High-sensitivity CRP drawn at baseline (when available) and in the early post-collision window.
• Selected cytokine or acute-phase markers when the clinical picture suggests a robust inflammatory drive.
• Metabolic measures (fasting glucose and insulin, HOMA-IR, advanced lipid panels, micronutrient indices) that identify co-factors that can amplify soft-tissue recovery demands.
• Serial draws that document the response trajectory as care continues.

Because the draws are dated relative to the known collision, the resulting record isolates the acute increment. An attorney can then present a before-and-after comparison rather than an isolated abnormal value. The same numbers also identify reversible metabolic contributors. For example, elevated inflammatory signaling and insulin resistance increase the rationale for nutrient-dense Advanced IV protocols and targeted nutritional support. These support interventions address root drivers of delayed recovery. These interventions are framed as medically necessary components of future care. They are not elective wellness services.

Further discussion of how inflammatory and metabolic markers inform clinical decision-making appears in the clinic’s resources on inflammation pathways and integrative systems biology.

Bioethical Framework Guiding the Work

Three principles shape how the panels are obtained and used. Beneficence is served when the data identify modifiable metabolic factors that can be addressed through Advanced IV support and nutrition, accelerating recovery of soft-tissue and neurologic function rather than simply suppressing symptoms. In addition, non-maleficence is advanced by prioritizing these drug-sparing measures; patients gain options that reduce the likelihood of prolonged reliance on anti-inflammatory or analgesic medications and their associated risks. Autonomy is preserved by sharing the laboratory results and interpretive notes with the patient’s primary physician. In this way, treatment decisions remain collaborative and the patient retains control over the overall plan.

What Distinguishes the Clinic

Injury Medical Chiropractic and Functional Medicine Clinic is led by a dual-licensed clinician, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, who specializes in soft-tissue injury evaluation and management and works in continuous collaboration with Dr. Maria Guadalupe Cardenas, MD, as Medical Director. This structure allows the clinic to interpret laboratory panels, structural findings, and functional measures together in a single record. Furthermore, the clinic is one of the only practices in El Paso, Texas, that integrates these scopes under one medical director and advanced-practice clinician for personal-injury patients. The resulting documentation is therefore both clinically coherent and ready for attorney review.

These timed markers strengthen proving causation in car-accident cases within the broader framework presented at dralexjimenez.com. Related discussions of pre-accident baseline reconstruction and the handling of pre-existing condition defenses are available on the same site. Also, resources explaining inflammatory and metabolic pathways relevant to recovery are there.

Practical Documentation Steps for Counsel

Attorneys working with the clinic typically receive:

• Clear notation of the collision date and the exact draw dates of each panel.
• Comparison language that distinguishes any available pre-accident values from post-accident results.
• Correlation of laboratory change with clinical findings (digital range-of-motion, AOMSI measurements, or functional limitations) so the metabolic data is not presented in isolation.
• Explicit statements of medical necessity for the Advanced IV and nutritional elements that the panels support.

When these elements are present, the pre-existing-disease defense is met with a dated, objective record rather than competing narratives. The Eggshell Plaintiff Rule is thereby given the evidentiary foundation it requires.

---

References

Xu, L. B., Yue, J. K., Korley, F., Puccio, A. M., Yuh, E. L., Sun, X., Rabinowitz, M., Vassar, M. J., Taylor, S. R., Winkler, E. A., Puffer, R. C., Deng, H., McCrea, M., Stein, M. B., Robertson, C. S., Levin, H. S., Dikmen, S., Temkin, N. R., Giacino, J. T., Mukherjee, P., … Manley, G. T. (2021). High-sensitivity C-reactive protein is a prognostic biomarker of six-month disability after traumatic brain injury: Results from the TRACK-TBI study. Journal of Neurotrauma, 38(7), 918–927. doi.org/10.1089/neu.2020.7177

Brinjikji, W., Luetmer, P. H., Comstock, B., Bresnahan, B. W., Chen, L. E., Deyo, R. A., Halabi, S., Turner, J. A., Avins, A. L., James, K., Wald, J. T., Kallmes, D. F., & Jarvik, J. G. (2015). Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. American Journal of Neuroradiology, 36(4), 811–816. doi.org/10.3174/ajnr.A4173

Guevara v. Ferrer, 247 S.W.3d 662 (Tex. 2007).

Jelinek v. Casas, 328 S.W.3d 526 (Tex. 2010).

State Bar of Texas. (2018). Texas pattern jury charges: General negligence, intentional personal torts. State Bar of Texas.